Français English
cabinet ophtalmo bordeaux Prendre rendez-vous Book an appointment

Publications


In french In english

[08/06/2020] COMPARATIVE EFFECTIVENESS OF PROTON BEAM VERSUS PHOTODYNAMIC THERAPY TO SPARE THE VISION IN CIRCUMSCRIBED CHOROIDAL HEMANGIOMA.



COMPARATIVE EFFECTIVENESS OF PROTON BEAM VERSUS PHOTODYNAMIC THERAPY TO SPARE THE VISION IN CIRCUMSCRIBED CHOROIDAL HEMANGIOMA.
Mathis T, Maschi C, Mosci C, Espensen CA, Rosier L, Favard C, Tick S, Remignon CH, Ligorio P, Bonin N, Gambrelle J, Nguyen AM, Faber C, Meyer L, Mouriaux F, Herault J, Baillif S, Kiilgaard JF, Kodjikian L, Caujolle JP, Salleron J, Thariat J.
Retina. 2020 May 12. doi: 10.1097/IAE.0000000000002843. Online ahead of print.PMID: 32404844
Detail

[04/12/2019] Diagnosis and treatment of peripheral exudative haemorrhagic chorioretinopathy.

 

Diagnosis and treatment of peripheral exudative haemorrhagic chorioretinopathy.

Vandefonteyne S, Caujolle JP, Rosier L, Conrath J, Quentel G, Tadayoni R, Maschi C, Le Mer Y, Dot C, Aknin I, Thariat J, Baillif S.

Br J Ophthalmol. 2019 Oct 23. pii: bjophthalmol-2018-313307. doi: 10.1136/bjophthalmol-2018-313307


Detail

[10/10/2019] [Management of uveal melanomas, guidelines for oncologists]

 
[Management of uveal melanomas, guidelines for oncologists].
Mathis T, Cassoux N, Tardy M, Piperno S, Gastaud L, Dendale R, Maschi C, Nguyen AM, Meyer L, Bonnin N, Baillif S, Tick S, Mouriaux F, Jaspart F, Dellis J, Rosier L, Desjardins L, Herault J, Caujolle JP, Thariat J.Bull Cancer. 2018 Oct;105(10):967-980. doi: 10.1016/j.bulcan.2018.07.011. Epub 2018 Sep 1
Detail

[06/09/2019] Communication orale Euretina 2019

National survey on the management and information practices of patients with wet AMD. Eric FOURMAUX1, Bénédicte BRIEND2, Marie-Laure LE LEZ3, Hélène MASSE4, Franck RUMEN5, Pierre GRIFFON6, Salomon-Yves COHEN7
 
Detail

[06/09/2019] Film Lasso Technique Euretina Congress Paris

Md Laurent Velasque present a film named "Lasso technique" for implantation intrascleral iol.
Detail

[06/09/2019] Hulc Study Poster Euretina Congress Paris 2019.

MD Laurent VELASQUE, M LAPEYRE, M DOMINGUEZ, E FOURMAUX, L ROSIER, C SEGUY.

Heads Up Learning Curve with 3D system surgical system
Detail

[06/09/2019] LUX Study Poster Euretina Congress Paris 2019.

MD Laurent VELASQUE , A HANDAYE DESSUS, M DOMINGUEZ, E FOURMAUX, L ROSIER, C SEGUY.
Contribution of a heads-up system with a low light sensitive camera to a significant decrease of the endoillumination during ocular surgeries, compensated by the brightness of the screen


Detail

[01/09/2019] Effectiveness and safety of intravitreal aflibercept in patients with wet age- related macular degeneration treated in routine clinical practices across France: 12-month outcomes of the RAINBOW study

British Medical Journal publication of  RAINBOW Study results 

Michel Weber,1 Laurent Velasque,2 Florence Coscas,3,4 Céline Faure,5
Isabelle Aubry,6 Salomon Y Cohen,7 on behalf of the RAINBOW study investigators
 

BMJ Open Ophthalmology 2019;4:e000109.


Detail

[04/04/2019] Pitfalls and diagnostic difficulties in detecting bilateral macular edema. Ophthalmo logical Realities . 20 19 ; 259 : 50 -1

M.LAPEYRE, L.VELASQUE, L.ROSIER, M.DOMINGUEZ, E.FOURMAUX, C.SEGUY
Pitfalls and diagnostic difficulties in detecting bilateral macular edema. Ophthalmo logical Realities . 20 19 ; 259 : 50 -1
Detail

[17/02/2019] The Lens Opacities Classification System III grading in irradiated uveal melanomas to characterize proton induced cataracts.

 Mathis T, Rosier L, Meniai F, Baillif S, Maschi C, Herault J, Caujolle JP, Kodjikian L, Salleron J, Thariat J. Am J Ophthalmol. 2019 Feb 2. pii: S0002-9394(19)30046-7. doi: 10.1016/j.ajo.2019.01.025. [Epub ahead of print
Detail

[27/09/2018] EURETINA 2018 Communication

S. Baillif, L. Kodjikian, E. Fourmaux, F. Coscas, C. Faure, S. Cohen, M. Weber FRANCE
A real-world study to monitor wet age-related macular degeneration patients treated with intravitreal aflibercept: 12-month outcomes of RAINBOW stratified by treatment regimen
Detail

[14/02/2018] Cataract Avoidance with Proton Therapy in Ocular Melanomas

Cataract Avoidance with Proton Therapy in Ocular Melanomas
Juliette Thariat; Sophie Jacob; Jean-Pierre Caujolle; Celia Maschi; Stéphanie Baillif; Gaelle Angellier; Thibaud Mathis; Laurence Rosier; Adela Carnicer; Joel Hérault; Julia Salleron
IOVS investigative ophthalmology visual science october 2017 Vol.58,No.12
Detail

[10/05/2017] Poster ARVO 2017 Baltimore USA

Real-world outcomes with ranibizumab 0.5 mg in treatment-naïve French patients with visual impairment due to diabetic macular edema: 12-month results from the ETOILE study
Eric Fourmaux, Amélie Lecleire-Collet,Corinne Dot,Marie-Laure Le Lez,Stéphanie Baillif,Ali Erginay,Eric Souied,Philippe Gain,Laetitia Finzi,Laurent Kodjikian
 
Detail

[07/05/2017] Poster ARVO 2017 Batimore USA

Evaluation of time-to-recurrence of disease activity in treatment-naïve patients with neovascular age-related macular degeneration after ranibizumab treatment: 12-month analysis from the ORACLE study
Maddalena Quaranta,François Devin,Gabriel Quentel,Joël Uzzan, Eric Fourmaux, Laurent Castelnovo,Wilfried Roquet,Catherine Francais-Maury,Sam Razavi,Nathalie San Nicolas

 
Detail

[05/05/2017] Communication SFO the RAINBOW Study Real-Life Use of Intravitreal Aflibercept In France: observational study in Wet Age-Related Macular Degeneration:

Michel Weber1, Laurent Velasque2, Florence Coscas3, Celine Faure4, Stéphanie Baillif5, Vincent Parier6, Salomon-Yves Cohen7
 
1. CHU Hôtel-Dieu, Nantes; 2. Centre du Palais Galien, Bordeaux; 3. Centre Odéon, Paris; 4. Clinique Saint Martin, Caen; 5. CHU Nice, Nice; 6. Clinique Mitivet, St Maur des Fosses; 7. CIL, Paris.
Detail

[10/02/2017] Poster ASCRS Maastricht

Poster presented in ASCRS ( American Society of Cataract and Refractiv Surgery ) Congress Maastricht Netherlands
Multicenter evaluation of Time, Operational and Economic Efficiencies of a New Pre-loaded IOL delivery system vs manual IOL delivery . Mendicute J1, Júlvezm L2, Schweitzer C3, Vélasque L4, Martinez A5
1Hospital Universitario Donostia Servicio de Oftalmología. 2Hospital Universitario Miguel Servet Servicio de Oftalmología . 3Service d’Ophtalmologie du Pr KOROBELNIK – Hôpital Pellegrin. 4Centre Retine Gallien Bordeaux. 5Alcon Laboratories, Inc., Fort Worth, TX
 
Detail

[15/01/2017] Ultrasert Study APACRS Congress

EU UltraSert TnM Study abstract_APACRS
Detail

[23/09/2016] Visual Outcomes of Parapapillary Uveal Melanomas following Proton beam Therapy


Juliette Thariat, MD, PhD, Jean-Daniel Grange, MD, Carlo Mosci, MD, Laurence Rosier, MD, Celia Maschi, MD, Francesco Lanza, MD, Anh Minh Nguyen, MD, Franck Jaspart, MD, Franck Bacin, MD, PhD, Nicolas Bonnin, MD, David Gaucher, MD, Wolfgang Sauerwein, MD, PhD, Gaelle Angellier, PhD, Joel Hérault, P, Jean-Pierre Caujolle
Radiat Oncol Biol Phys. 2016;95(1) : 328-35 
Detail

[01/09/2016] ARVO Annual Meeting Abstract September 2016 Real Life Use of Aflibercept In FraNce: oBservatiOnal study in Wet AMD: the RAINBOW study

  • ARVO Annual Meeting Abstract September 2016
  • Real Life Use of Aflibercept In France: Observational study in Wet AMD: the RAINBOW study 

    OUBRAHAM-MEBROUKINE Hassiba; Celine Faure; Florence Coscas; Thi Ha Chau Tran; Benedicte Briend-Joulain; Laurent Velasque; Isabelle Aubry; Michel Weber; Salomon Y CohenInvest. Ophthalmol. Vis. Sci.. 2016; 57(12):524. doi:

Detail

[04/05/2016] Poster ARVO 2016 :

Time to recurrence in neovascular age-related macular degeneration after ranibizumab treatment: baseline characteristics of treatment-naïve patients enrolled in the ORACLE study
Francois Devin, Eric Fourmaux, Gabriel Quentel, Joel Uzan, Maddalena Quaranta El-Maftouhi, Catherine Francais-Maury, Wilfried Roquet, Laurent Castelnovo, Sam Razavi, Laetitia Finzi
Invest. Ophthalmol.Vis. Sci.. 2016, Vol.57, 3353. doi:
 
Detail

[03/05/2016] Poster ARVO 2016 :

Real Life Use of Intravitreal Aflibercept In FraNce: oBservatiOnal study in Wet AMD: the RAINBOW study
Hassiba Oubraham-Mebroukine, Céline Faure, Florence Coscas, Thi Ha Chau Tran, Benedicte Briend-Joulain, Laurent Velasque,
Isabelle Aubry, Michel Weber, Salomon-Yves Cohen
Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):524. doi:
Detail

[16/11/2015] Corrigendum to Strategy for the Management of Diabetic Macular Edema

The European Vitreo-Retinal Society Macular Edema Study".

Adelman RA, Parnes AJ, Michalewska Z, Parolini B, Boscher C, Ducournau D; EVRS Macular Edema Study Group.

Biomed Res Int. 2015;2015:694902. doi: 10.1155/2015/694902. Epub 2015 Dec 20.


Detail

[06/11/2015] Intravitreal ranibizumab combined with verteporfin photodynamic therapy in the management of wet age-related macular degeneration in routine clinical practice in France: the AURORE study.

Franck Rumen, Dominique Pawlak, Christian Malbrel, Wilfred Roquet, Joël Uzzan, Alain Chouquet, Christian Delhay, Jean-Claude Quintyn, Eric Fourmaux, Alain Deudon-Combe, Walid Michel Haddad, David Sayag, Elizabeth Latour†, Laetitia Finzi.
Detail

[01/09/2014] Clinical variables associated with failure of retinal detachment repair: the European vitreo-retinal society retinal detachment study report number 4.

Adelman RA, Parnes AJ, Michalewska Z, Ducournau D; European Vitreo-Retinal Society (EVRS) Retinal Detachment Study Group. Ophthalmology. 2014 Sep;121(9):1715-9. doi: 10.1016/j.ophtha.2014.03.012. Epub 2014 Apr 22.
Detail

[03/05/2014] Poster ARVO 2014 :

RAVE  2 Study : Two years treatment follow up with intravitreal ranibizumab (Lucentis®) and verteporfin PDTRF  combination therapy at month 2 for neovascular age-related macular degeneration (AMD)
M. Dominguez – E. Fourmaux - L. Rosier - L. Velasque    Centre Rétine Gallien  Bordeaux - France
Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3961. doi:
 
Detail

[07/09/2013] Comparison of clinical efficacy: Nd:YAG laser rates after implantation of AcrySof® SN60WF, Akreos® AO-MI60 and Hoya® YA-60BB.

Bourdiol Ducasse AM, Guerzider V, Velasque L, Dominguez M, Lafuma A, Robert J. J Fr Ophtalmol. 2013 Sep;36(7):575-82


Detail

[02/09/2013] Strategy for the management of complex retinal detachments: the European vitreo-retinal society retinal detachment study report 2.

Adelman RA, Parnes AJ, Sipperley JO, Ducournau D; European Vitreo-Retinal Society (EVRS) Retinal Detachment Study Group. Ophthalmology. 2013 Sep;120(9):1809-13. doi: 10.1016/j.ophtha.2013.01.056. Epub 2013 Apr 17.
Detail

[01/09/2013] Strategy for the management of uncomplicated retinal detachments: the European vitreo-retinal society retinal detachment study report 1.

Adelman RA, Parnes AJ, Ducournau D; European Vitreo-Retinal Society (EVRS) Retinal Detachment Study Group. Ophthalmology. 2013 Sep;120(9):1804-8. doi: 10.1016/j.ophtha.2013.01.070. Epub 2013 Apr 16.
Detail

[05/05/2012] Poster ARVO 2012 :

One year’s treatment with intravitreal ranibizumab (Lucentis®) and verteporfin PDT  combination therapy at month 2 for neovascular age-related macular degeneration (AMD)
E. Fourmaux - M. Dominguez - L. Rosier - L. Velasque  Rétine Gallien  Bordeaux - France
Detail

[06/09/2008] 8th European VitreoRetinal Society congress, Prague

My way in…Pseudophakic retinal detachment surgery  -  M. Dominguez, MD
Detail

[01/10/2006] BEST disease. Ophthalmoscopic and OCT views

​Rosier L, Velasque L, Dominguez M.
J Fr Ophtalmol. 2006 Oct;29(8):959.


Detail

[01/11/2005] Spontaneous retrohyaloid hemorrhage treated with YAG laser].

Velasque L, Dominguez M, Rosier L.
J Fr Ophtalmol. 2005 Nov;28(9):1007.


Detail

[25/09/2005] Complications and lack of benefit after transpupillary thermotherapy for occult choroidal neovascularization: 1-year results

Rougier MB, Francois L, Fourmaux E, Isber R, Colin J, Korobelnik JF. 
Retina. 2005 Sep;25(6):784-8.
 
Detail

[19/04/2004] Laser photocoagulation for choroidal neovascular membrane associated with optic disc

Delyfer MN, Rougier MB, Fourmaux E, Cousin P, Korobelnik JF.    Ophthalmol Scand. 2004 Apr;82(2):236-8.
Detail

[30/06/1999] Results of proton therapy of uveal melanomas treated in Nice.

Courdi A, Caujolle JP, Grange JD, Diallo-Rosier LR, Sahel J.  Int J radiat oncol Biol Phys. 1999;45:5-11
Detail

[30/06/1994] Technical considerations about protontherapy and visual conservation for uveal melanomas: The experience of the SERAG.

Chauvel P,Brassart N,Herault J,Courdi A,CaujolleJP,Grange JD, Mouries O, Diallo-Rosier L, Mosci C, Polizzi A, Porta A, Menci E, Bornfeld N, Friedrichs W, Sahel J, Bacin F, Ge ́rard JP, Sauerwein W, Scolaro T, Carrie C, Kantor G, Rozan R, Teissier T, Bensadoun RJ, Lagrange JL, Demard F. Technical considerations about protontherapy and visual conservation for uveal melanomas: The experience of the SERAG. In: Frezzotti R, Balestrazzi E, Falco L, Esente S, editors. International Symposium on Intraocular and Epibulbar Tumors. Bologna: Monduzzi Editore; 1994. p. 99– 103.
Detail